Intest Res.
2010 Dec;8(2):177-180. 10.5217/ir.2010.8.2.177.
A Pityrosporum Fungal Infection Following Infliximab Therapy in a Crohn's Disease Patient
- Affiliations
-
- 1Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea. skkim@mail.knu.ac.kr
- KMID: 2284936
- DOI: http://doi.org/10.5217/ir.2010.8.2.177
Abstract
- Crohn's disease (CD) is a chronic immune-mediated inflammatory disorder. Treatment strategies for CD are targeted toward various components of the proinflammatory mediators and subsequent immune response. Recently, the anti-tumor necrosis factor (TNF) monoclonal antibody, infliximab has been used in patients with CD. However, uncommon and unusual infections have been reported during anti-TNF-alpha therapy and immunomodulator. Here, we report a case of pityriasis versicolor occurring in a patient with CD receiving infliximab treatment. The patient was successfully treated with topical ketoconazole.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
- A Case of Multiple Tuberculosis Associated with Infliximab Therapy in Crohn's Disease
- Recent Trends of Infliximab Treatment for Crohn's Disease
- Development of Renal Disorder in a Patient Receiving Infliximab (Remicade(R)) for Psoriasis
- Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
